Cargando…

New molecular aspects in pathogenesis and progression of pancreatic cancer

Detalles Bibliográficos
Autores principales:	Büchler, Peter, Büchler, Markus W, Friess, Helmut
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC149415/ http://dx.doi.org/10.1186/1476-4598-2-11

Ejemplares similares

Invasion and metastasis in pancreatic cancer
por: Keleg, Shereen, et al.
Publicado: (2003)

A proposal for a new clinical classification of chronic pancreatitis
por: Büchler, Markus W, et al.
Publicado: (2009)

Splenic and portal vein thrombosis in pancreatic metastasis from Renal cell carcinoma
por: Shrikhande, Shailesh V, et al.
Publicado: (2006)

Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003)

Pancreatic metastasis from gastric carcinoma: a case report
por: Wente, Moritz N, et al.
Publicado: (2004)

Corticosteroid co-treatment induces resistance to chemotherapy in surgical resections, xenografts and established cell lines of pancreatic cancer
por: Zhang, Chengwen, et al.
Publicado: (2006)

Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells
por: El Fitori, Jamael, et al.
Publicado: (2005)

Pancreatic metastasis of Merkel cell carcinoma and concomitant insulinoma: Case report and literature review
por: Bachmann, Jeannine, et al.
Publicado: (2005)

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
por: Li, Junsheng, et al.
Publicado: (2005)

Pancreatic cancer — lessons from the past decade
por: Demir, Ihsan Ekin, et al.
Publicado: (2015)

Pancreatic cancerrelated cachexia: influence on metabolism and correlation to weight loss and pulmonary function
por: Bachmann, Jeannine, et al.
Publicado: (2009)

Second-Look Operation for Unresectable Pancreatic Ductal Adenocarcinoma at a High-Volume Center
por: Michalski, Christoph W., et al.
Publicado: (2007)

Necro-inflammatory response of pancreatic acinar cells in the pathogenesis of acute alcoholic pancreatitis
por: Gu, H, et al.
Publicado: (2013)

Current State of Surgical Management of Pancreatic Cancer
por: Hackert, Thilo, et al.
Publicado: (2011)

Autoimmune Pancreatocholangitis, Non-Autoimmune Pancreatitis and Primary Sclerosing Cholangitis: A Comparative Morphological and Immunological Analysis
por: Esposito, Irene, et al.
Publicado: (2008)

Current State of Vascular Resections in Pancreatic Cancer Surgery
por: Hackert, Thilo, et al.
Publicado: (2015)

Pancreatic Cancer: Molecular, Biochemical, Chemopreventive, and Therapeutic Aspects
por: Iovanna, Juan, et al.
Publicado: (2010)

Medical and Surgical Conditions for the Treatment of Malabsorption
por: Kadmon, Martina, et al.
Publicado: (2014)

Duodenum preserving pancreatectomy in chronic pancreatitis: Design of a randomized controlled trial comparing two surgical techniques [ISRCTN50638764]
por: Köninger, Jörg, et al.
Publicado: (2006)

New Aspects of the Epigenetics of Pancreatic Carcinogenesis
por: Toruner, Murat, et al.
Publicado: (2020)

Local radicality and survival outcome of pancreatic cancer surgery
por: Niesen, Willem, et al.
Publicado: (2019)

The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?
por: D’Haese, Jan G, et al.
Publicado: (2013)

Surgical Treatment of Necrotizing Pancreatitis
por: Uhl, W., et al.
Publicado: (1997)

Clinical Impact of Molecular Subtyping of Pancreatic Cancer
por: Zhou, Xu, et al.
Publicado: (2021)

PHD3 regulates differentiation, tumour growth and angiogenesis in pancreatic cancer
por: Su, Y, et al.
Publicado: (2010)

Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
por: Cantero, D., et al.
Publicado: (1997)

New Insights into Pathogenesis, Diagnosis, and Treatment of Pancreatic Disorders
por: Rydzewska, Grazyna, et al.
Publicado: (2013)

Corrigendum: Clinical impact of molecular subtyping of pancreatic cancer
por: Zhou, Xu, et al.
Publicado: (2023)

VENUSS rising for papillary renal cell carcinoma prognostication?
por: Buchler, Tomas
Publicado: (2020)

Hormone-Dependent Cancers: New Aspects on Biochemistry and Molecular Pathology
por: Miki, Yasuhiro
Publicado: (2023)

BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation
por: Hennig, R, et al.
Publicado: (2008)

Molecular Aspects of Cellular Dysfunction in Alzheimer’s Disease: The Need for a Holistic View of the Early Pathogenesis
por: Merlo, Sara, et al.
Publicado: (2021)

Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
por: Filipovic, Branka, et al.
Publicado: (2023)

Distribution pattern and molecular signature of cholinergic tuft cells in human gastro-intestinal and pancreatic-biliary tract
por: Schütz, Burkhard, et al.
Publicado: (2019)

Rheumatic Diseases: New Progress in Clinical Research and Pathogenesis
por: Koo, Malcolm, et al.
Publicado: (2023)

Molecular aspects of poliovirus pathogenesis
por: Nomoto, Akio
Publicado: (2007)

Neurotensin receptors in pancreatic ductal carcinomas
por: Körner, Meike, et al.
Publicado: (2015)

Combining forces to hit cancer stem cells: TRAIL-lymphocytes and EpCAMxCD3 bispecific antibody show efficacy against pancreatic cancer
por: Herr, Ingrid, et al.
Publicado: (2012)

Molecular System Bioenergetics—New Aspects of Metabolic Research
por: Saks, Valdur
Publicado: (2009)

Refining the Treatment of Pancreatic Cancer From Big Data to Improved Individual Survival
por: Bailey, Peter, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4irj8icvocco2vsrrr4pqpetok